A sharp sell-off in gold and silver, alongside falling oil prices, has sparked volatility across global markets at the start of a week packed with major earnings and central bank decisions.
Eli Lilly's CEO sees Medicare's new policy covering obesity treatments as a pivotal moment, poised to unlock access for millions of beneficiaries to its incoming oral drug, orforglipron, and intensify the market battle with Novo Nordisk.
In the shadow of tech giants, two quantum computing specialists, IonQ and D-Wave Quantum, are vying for investor attention with distinct approaches to AI. While both remain speculative bets, a closer look at their technology, finances, and market position reveals one as a potentially less volatile choice for those venturing into this frontier.
Rising global defense budgets are accelerating the adoption of artificial intelligence in military systems, with companies racing to develop advanced sensing and threat-detection capabilities through strategic partnerships and acquisitions.
Amid a resilient but mixed market, companies with significant insider ownership are drawing investor attention. We examine three firms—spanning crypto, consumer staples, and finance—where management's substantial equity stakes align with ambitious earnings growth forecasts of up to 124%.
While major indices capture headlines, a deeper look reveals potential in select small-cap banks. We analyze three financial institutions with strong fundamentals, strategic moves, and valuations that may offer compelling opportunities for discerning investors.
As markets navigate a volatile start to 2026, income-focused investors are turning to dividend payers for resilience. We analyze three companies with strong cash flows and shareholder return commitments.
ZJK Industrial Co., Ltd. (NASDAQ:ZJK) has seen its shares tumble 25% in three months. We analyze whether its mixed financial fundamentals, including a middling Return on Equity and stagnant earnings, justify the market's pessimistic stance.
While stocks priced between $10 and $50 can appear to offer an attractive balance of accessibility and maturity, not all are sound investments. We examine three companies in this range whose valuations and business prospects raise significant red flags for discerning investors.
A landmark investment proposal between AI titans Nvidia and OpenAI has stalled, with both companies reassessing terms amid internal concerns and a shifting competitive landscape, according to a Wall Street Journal report.
Foundation Investment Partners, through its platform Sustainable Packaging, has acquired Paper Converters, a Walterboro-based manufacturer of spiral-wound paper tubes and boards, marking a strategic consolidation in the eco-friendly packaging sector.
Afya Ltd., a leading medical education group in Brazil, is demonstrating robust financial health with a rising Return on Capital Employed (ROCE) and significant capital expansion. While its stock has faced headwinds, the underlying operational metrics suggest a company efficiently reinvesting for growth, presenting a potential opportunity for value-focused investors.
The fast-growing sunscreen brand Supergoop has named former Peloton marketing chief Lauren Weinberg as its new CMO, tasking her with expanding the brand's cultural footprint and driving growth across digital and product innovation.
While the S&P 500 is a benchmark for market stability, a closer look reveals diverging fortunes. We analyze one component with strong fundamentals poised for growth and two others where investors should exercise caution.
While rapid growth can inflate valuations, its sustainability separates market leaders from laggards. We analyze one company extending its competitive moat and two others where investors should tread carefully.
Despite a strong three-year run, shares of Ollie's Bargain Outlet (OLLI) dipped this week, prompting investors to weigh its solid earnings growth against recent market performance.
Oracle announces plans to raise up to $50 billion in 2026 through debt and equity to massively expand its cloud data centers, aiming to meet surging demand from AI leaders like Nvidia, OpenAI, and xAI.
While investors chase AI and big tech, a niche biotech firm focused on rare genetic obesity disorders has quietly delivered staggering returns, with Wall Street seeing further 40% upside. Rhythm Pharmaceuticals' targeted approach and upcoming catalysts have analysts bullish, despite its relative anonymity.
Following a significant pullback, NetEase (SEHK: 9999) shares are trading at levels that some analysts deem undervalued. We examine the financial models, peer comparisons, and the broader sector headwinds facing the Chinese gaming giant to assess if the current price presents a strategic entry point for long-term investors.
Investors in U.S. spot Bitcoin ETFs are holding significant paper losses on average, sparking concerns that a wave of redemptions could intensify the cryptocurrency's recent downturn.
